|
The FDA's Division of Drug Marketing, Advertising and Communications has informed Bracco Diagnostics that its Web site for IsoVue (iopamidol injection) misbrands the drug by omitting and minimizing the risks associated with the agent and contains false and unsubstantiated claims.
Time-resolved MR angiography (TR-MRA) is a useful sequence for the assessment of ovarian vein reflux, which may aid the evaluation of pelvic congestion syndrome, according to research published this month in the American Journal of Roentgenology.
There is no significant difference between iodixanol (Visipaque, GE Healthcare) and iopamidol (IsoVue, Bracco Diagnostics) in either peak increase in serum creatinine or risk of contrast-induced nephropathy, according to a prospective, multicenter, randomized, double-blind trial in the November issue of the American Heart Journal.
The world medical ultrasound equipment, accessories, and maintenance services market is expected to reach $4.7 billion by 2012, according to market research firm Marketstrat.
The U.S. District Court in Trenton, N.J. has ruled that GE Healthcare and its predecessor companies, including Amersham, engaged in a false and misleading advertising with a promotional campaign claiming that its x-ray contrast agent Visipaque was superior to Bracco's x-ray contrast agent Isovue.
Bracco Diagnostics (Booth 2845), along with ACIST Medical Systems, is showcasing a portfolio of imaging agents and delivery systems, such as MultiHance, which is indicated for intravenous use in MRI of the central nervous system in adults to visualize lesions with abnormal blood brain barrier or abnormal vascularity of the brain, spine and associated tissues.
|
Bracco Diagnostics has selected Datalliance VMI as the platform for its vendor managed inventory program.
Bracco Diagnostics and Acist Medical Systems (Booth #2829) are featuring the updated EmpowerCTA contrast injector, with the integrated IRiSCT data management system for diagnostic imaging in radiology at the 2009 Radiological Society of North America (RNSA).
Volumetric oblique coronal reformations are a useful noninvasive method to provide diagnostic information about periampullary abnormalities as well as show secondary features important for local staging and management of the ampulla of Vater, according to research published this month in the American Journal of Roentgenology.
Past studies have indicated a benefit regarding the use of an iso-osmolar contrast agent versus low-osmolar contrast media. A new meta-analysis in the July issue of JACC: Cardiovascular Interventions suggests the two types of contrast agents are equivalent in terms of the risk of acute kidney injury.
Bracco Imaging unveiled its expanded product portfolio at the 2008 RSNA, including contrast media and delivery systems for CT/cardiology, MRI, nuclear medicine and virtual colonoscopy (VC).
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.